The company said Organic Sales Growth for Q2 FY ’26 was +0% and Organic Volume Growth was -1%, and Core EPS was flat with the prior year at $1.88. The company said Pricing contributed +1%, offset by volume at -1%.

1. 01

   The company said Organic Sales Growth for Q2 FY ’26 was +0% and Organic Volume Growth was -1%, and Core EPS was flat with the prior year at $1.88. The company said Pricing contributed +1%, offset by volume at -1%.

2. 02

   P&G reported Diluted EPS of $1.78 for the three months ended December 31, 2025, and Core EPS of $1.88 including incremental restructuring of 0.10. The company said Currency-Neutral Core EPS, reflecting a currency impact to earnings of 0.03, was $1.85.

3. 03

   The company said operating cash flow was $4,972, capital spending was $(1,167), adjusted free cash flow was $3,805 and net earnings was $4,331 for the three months ended December 31, 2025 (in millions), and adjusted free cash flow productivity was 88%.

4. 04

   The company said it maintained its FY 2026 Organic Sales Growth at +0% to +4% and Core EPS Growth at +0% to +4%. Procter & Gamble also said it updated its All-in EPS Growth to +1% to +6%.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.